ART5803
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ART5803, covering 2025-09-25 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of ART5803 in Healthy Participants [Phase 1]